Acne Medication Market - Top Companies and Manufacturers

  • Report ID: 6417
  • Published Date: Sep 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Acne Medication Landscape

    The acne medication market is quite competitive owing to the presence of established players and the entry of start-ups such as Stryke Club, Derm-Biome Pharmaceuticals, Legit Health, and Dermatica. The key players in the market are mainly focused on the production of advanced medications for acne care, whereas new companies on offering cutting-edge AI-based skin care solutions.

    • Bausch Health Companies Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Mayne Pharma Group Limited
    • GlaxoSmithKline Plc.
    • Pfizer Inc.
    • Mylan N.V.
    • Galderma S.A.
    • Cosmo Pharmaceuticals SA
    • Teva Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • Zydus Lifesciences Limited
    • Almirall Sa
    • Crown Laboratories
    • Nivea
    • Sun Pharmaceutical Industries Limited

Browse Key Market Insights with Data Illustration:

In the News

  • In December 2022, Beiersdorf AG announced the acquisition of S-Biomedic NV to expand its expertise in acne treatment. S-Biomedic NV is a life science company advancing in skin microbiome research.
  • In July 2021, Sol-Gel Technologies received U.S. FDA Approval of TWYNEO a cream medication for treating acne vulgaris. TWYNEO is manufactured from the combination of tretinoin and benzoyl peroxide. 

Author Credits:  Radhika Pawar


  • Report ID: 6417
  • Published Date: Sep 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global acne medication market is estimated at USD 12.7 billion in 2025.

Expanding at a CAGR of 5.4%, the global market is anticipated to increase from USD 12.1 billion in 2024 to USD 23.3 billion by 2037.

Some of the leading companies are Galderma S.A., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., and Pfizer Inc.

Antibiotics are anticipated to capture 46.5% of the global market share by 2037.

North America leads the sales of acne medications and is expected to hold the dominance through 2037 owing to the high prevalence of acne and other skin-related disorders.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample